SCHEMBL5047640

SCHEMBL5047640

O=c1[nH]c2cc(F)cc(F)c2cc1CCN1CC[CH]CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 2/20 0.36
KCNH2 Q12809 7/20 0.35
PARP1 P09874 1/20 0.35
HTR2A P28223 7/20 0.34
HTR2C P28335 6/20 0.34
SLC6A2 P23975 1/20 0.34
SLC6A4 P31645 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
ALOX12 P18054 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34
ATM Q13315 1/20 0.34
DRD2 P14416 5/20 0.33
HTR1A P08908 2/20 0.33
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5050024 0.88 MPO (0.35) MPOKCNH2PARP1HTR2AHTR2C
SCHEMBL5050047 0.85 KCNH2 (0.35) MPOKCNH2PARP1HTR2AHTR2C
SCHEMBL5047695 0.85 PARP1 (0.38) KCNH2PARP1HTR2AHTR2CDRD2
SCHEMBL3846941 0.81 KCNH2 (0.47) MPOKCNH2PARP1HTR2AHTR2C
SCHEMBL5047576 0.77 EGLN1 (0.37) KCNH2PARP1HTR2AHTR2CSLC6A2
SCHEMBL3844281 0.72 PARP1 (0.37) MPOPARP1KDM4E
SCHEMBL4425807 0.72 GPR17 (0.52) PARP1CNR1
SCHEMBL5047668 0.72 HSD17B10 (0.35) KCNH2PARP1HTR2AHTR2CSLC6A2
SCHEMBL5051229 0.71 MPO (0.34) MPOKCNH2PARP1HTR2ASLC6A2
SCHEMBL3841830 0.70 GRIN1 (0.36) PARP1KDM4ECNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893599-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS AstraZeneca AB (SE) 2008-03-05 EP disclosed
WO-2006134378-A1 COMPOUNDS FOR THE TREATMENT OF MULTI-DRUG RESISTANT BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2006-12-21 WO disclosed